Search
Close this search box.

Day: February 5, 2024

Curia Receives 2024 CDMO Leadership Award

Curia recognized for its Service in the CDMO industry 2024 CDMO Leadership Award Curia Receives 2024 CDMO Leadership Award in the Service category. ALBANY, N.Y., Feb. 05, 2024 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization, today announced it has been awarded a 2024 CDMO Leadership Award in the Service category, […]

Read More »

Curia reçoit le CDMO Leadership Award 2024

Curia est ainsi reconnue pour son service dans le secteur des organisations de développement et de fabrication sous contrat ALBANY, New York, 05 févr. 2024 (GLOBE NEWSWIRE) — Curia, une organisation de développement et de fabrication sous contrat (CDMO) de premier plan, a annoncé aujourd’hui qu’elle avait reçu le CDMO Leadership Award 2024 dans la catégorie […]

Read More »

Curia recebe CDMO Leadership Award de 2024

Curia reconhecida pelo seu serviço na indústria de CDMO ALBANY, N.Y., Feb. 05, 2024 (GLOBE NEWSWIRE) — A Curia, uma organização líder em pesquisa, desenvolvimento e fabricação por contrato, anunciou hoje que recebeu um Prêmio de Liderança CDMO 2024 na categoria de Serviços do grupo Small Pharma. No seu 13º ano, os prêmios são apresentados […]

Read More »

Researchers at KFSH&RC & KAUST Discover Gene Responsible for Reproduction of the Most Dangerous Malaria Strain

Researchers at KFSH&RC & KAUST Discover Gene Responsible for Reproduction of the Most Dangerous Malaria Strain King Faisal Specialist Hospital and Research Center – Riyadh RIYADH, Saudi Arabia, Feb. 05, 2024 (GLOBE NEWSWIRE) — In a major scientific breakthrough, a research team from King Faisal Specialist Hospital and Research Centre (KFSH&RC), in collaboration with King […]

Read More »

Blue California completes groundbreaking human clinical trial on ErgoActive® ergothioneine intervention for cognitive function, memory, and sleep

Rancho Santa Margarita, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) — Blue California, an industry leader in science-driven ingredient development, announced the successful completion of a groundbreaking human clinical trial of ergothioneine. A double-blinded placebo-controlled clinical trial sponsored by Blue California has shown that ErgoActive® ergothioneine supports aspects of cognitive function, memory, and sleep in healthy […]

Read More »

Recent Posts

Advertisement